News
Bausch & Lomb Reports Weak Start to 2025 as enVista Recall, Tariffs, and Drug Pricing Cause Concerns
so contact lens wearers will usually purchase a new solution every three months. Biotrue is also a more expensive solution compared with generic alternatives, sometimes costing more than double ...
Bausch + Lomb is committed to sustainable practices that support people and communities worldwide.
Detailed price information for Bausch Lomb Corporation (BLCO-T) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results